InvestorsHub Logo
Followers 14
Posts 2848
Boards Moderated 0
Alias Born 12/23/2014

Re: mrholty post# 2142

Thursday, 02/15/2018 1:22:08 PM

Thursday, February 15, 2018 1:22:08 PM

Post# of 2463
Mike King is the owner of Princeton research and is the pr contact man for most of REPR's press releases.

http://www.princetonresearch.com/featured-investments/

Mike King
702 650 3000
Princeton Research
or
King Mike
mike@princetonresearch.com
(702) 493-3683

In alot of ways repr fills your criteria. The company is debt free and is funding future growth internally. This means its unlikely to have dilute secondary offerings. I do not see any negative surprises. The FDA thing has come and gone. I believe this was a blessing in disguise. It forced the company to upgrade its quality assurance procedures to the highest level. This can only help them marketing their products. The real sizzle lies in the potential propriety pump technology being used with other drugs. This could result in an avalanche of new orders and growth. Additionally the suction device res-q-vac, might eventually get into the military. This has been dangled in from of the stock holders for years. Who knows?